--- title: "Anticipatory Anhedonia: When the Brain Cannot Build Toward a Reward" slug: anticipatory-anhedonia-computational-psychiatry-reward-anticipation category: health category_label: "Health" author: "BrainWavePost Staff" date: 2026-08-27 tags: ["anhedonia", "depression", "computational psychiatry", "reward processing", "treatment-resistant depression", "personalized medicine", "Wellcome"] read_time_minutes: 9 canonical_url: https://brainwavepost.com/article/anticipatory-anhedonia-computational-psychiatry-reward-anticipation source: BrainWavePost --- # Anticipatory Anhedonia: When the Brain Cannot Build Toward a Reward *Health · 2026-08-27 · BrainWavePost Staff · 9 min read* > New computational psychiatry work argues that for many people with treatment-resistant depression, the deficit is not in feeling a reward — it is in the brain's ability to build anticipation over time. Here is what the anticipation-first model of anhedonia actually claims, and what remains unproven. > **Research explainer, not medical advice** _(note)_ > > This article summarises published research and funded research programs. Anhedonia is a clinical symptom; nothing here is diagnostic or treatment guidance. If you or someone you know is struggling, please consult a qualified professional. ## What is being claimed Anhedonia — the loss of pleasure and interest that sits at the core of major depression — is increasingly understood not as a single failure but as a breakdown that can occur at several distinct stages of reward processing: wanting (anticipation), liking (consummation), and learning (updating expectations from outcomes). [1] The anticipation-first account, now central to several multi-year research efforts, holds that for a substantial subgroup of people with treatment-resistant depression the consummatory system is relatively intact: these individuals can still feel pleasure when a reward arrives. What fails is the brain's capacity to dynamically build and sustain anticipation — to represent a future reward, hold that representation online, and let it grow as the reward approaches. [1][4] Wellcome Leap's $50 million Multi-Channel Psych (MCPsych) program is the largest dedicated effort in this space: it aims to build an integrated model of anhedonic depression that spans genes, molecules, cells, animal models and humans, precisely because single-level descriptions of anhedonia have failed to produce better treatments. [2][3] ## Why anticipation is a separate mechanism Behavioral and neuroimaging studies have repeatedly dissociated anticipatory from consummatory pleasure. A 2025 Schizophrenia Bulletin study framed anticipatory anhedonia transdiagnostically: in both schizophrenia and major depression, the core deficit involves maintaining a reward representation over time — the brain lets the picture of the future reward decay before it can guide motivation. [4] A 2026 BMC Psychiatry machine-learning analysis went further: across multiple behavioral measures, anticipatory pleasure was the single most informative hedonic component for distinguishing people with major depressive disorder from controls — more informative than consummatory pleasure or motivation alone. [5] That pattern matches the clinical observation behind the new initiatives: many treatment-resistant patients report that good events still feel fine in the moment, yet they cannot look forward to anything, cannot sustain effort toward delayed goals, and stop initiating rewarding activity — a profile standard antidepressants address poorly. [1][2] ## What computational psychiatry adds Instead of a questionnaire score, computational psychiatry fits formal models — typically reinforcement-learning models — to trial-by-trial behavior, yielding parameters such as reward learning rate, reward sensitivity, and the decay of value representations over time. A 2026 critical appraisal in Neuroscience & Biobehavioral Reviews reviews how these models of anhedonia are conceptualized and measured, and warns that tasks, models and clinical scales are often poorly aligned — one reason the field is now investing in synchronized, multi-level measurement rather than single studies. [1] The clinical promise is personalization: if one patient's anhedonia is dominated by blunted anticipation while another's is driven by impaired reward learning, the same treatment should not be expected to work for both. A 2026 Translational Psychiatry proof-of-concept trial showed that a neurocomputational training targeting reward learning and sensitivity could be delivered transdiagnostically to anhedonic individuals — an early example of treating a parameter rather than a diagnosis. [6] ## The accuracy box: what is solid and what is not - Solid: anticipatory, consummatory and learning components of reward processing dissociate behaviorally and neurally, and anticipatory deficits are prominent in depression and schizophrenia. [1][4][5] - Solid: large, multi-year, multi-level programs dedicated to the mechanisms of anhedonia exist and are funded at the tens-of-millions scale, explicitly because existing treatments underperform for this symptom. [2][3] - Not yet proven: that mapping individual anticipation dynamics across neural circuits will translate into personalized treatments that outperform current care. Proof-of-concept training studies are small and early. [1][6] - Careful with framing: 'the inability to build anticipation' is a leading mechanistic hypothesis for a subgroup of patients — not a settled explanation of treatment-resistant depression as a whole. [1] ## What to watch next 1. Whether anticipation-focused computational parameters prove stable and specific enough to serve as biomarkers that guide treatment selection. [1] 2. Whether mechanistic findings from multi-level programs like MCPsych converge on drug or stimulation targets that modulate anticipation specifically. [2][3] 3. Whether targeted interventions — neurocomputational training, behavioral activation variants, or circuit-targeted neuromodulation — show durable effects on anticipatory anhedonia in adequately powered trials. [6] ## Sources and further reading - [1] Neuroscience & Biobehavioral Reviews — The conceptualization, measurement, and critical appraisal of computational models of anhedonia in depression (2026): https://doi.org/10.1016/j.neubiorev.2026.106652 - [2] Wellcome Leap — MCPsych: Multi-Channel Psych program page ($50M program on anhedonic depression): https://wellcomeleap.org/programs/mcpsych/ - [3] Wellcome Leap — Program announcement: Revealing Mechanisms of Anhedonia: https://wellcomeleap.org/wp-content/uploads/2021/06/Program-Announcement-Multi-Channel-Psych-2021.pdf - [4] Schizophrenia Bulletin — Understanding Anticipatory Anhedonia in Schizophrenia and Depression: Linking Reward Representation Maintenance from a Transdiagnostic Perspective (2025): https://doi.org/10.1093/schbul/sbaf112 - [5] BMC Psychiatry — Anticipatory pleasure as a key hedonic component in classifying major depressive disorder (2026): https://doi.org/10.1186/s12888-026-08013-0 - [6] Translational Psychiatry — Neurocomputational training to boost reward learning and sensitivity in anhedonic individuals: a transdiagnostic proof-of-concept trial (2026): https://www.nature.com/articles/s41398-026-04355-1 --- _Canonical article: [https://brainwavepost.com/article/anticipatory-anhedonia-computational-psychiatry-reward-anticipation](https://brainwavepost.com/article/anticipatory-anhedonia-computational-psychiatry-reward-anticipation) — © BrainWavePost. Educational content; see the article page for full disclaimers._